Animal NDC 66104-8853-0 Neo-terramycin 100/100d
Neomycin-oxytetracycline
Animal Product Information
| Field Name | Field Value |
|---|---|
| Animal NDC Code | 66104-8853-0 |
| Proprietary Name | Neo-terramycin 100/100d What is the Proprietary Name? The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. |
| Non-Proprietary Name | Neomycin-oxytetracycline What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. |
| Labeler Name | Phibro Animal Health |
| Product Type | Vfd Type A Medicated Article Animal Drug |
| Usage Information |
|
| Active Ingredient(s) |
|
| Inactive Ingredient(s) |
|
| Marketing Category | NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| FDA Application Number | NADA094975 What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
Neo-terramycin 100/100d Images
Neo-terramycin 100/100d Animal Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Table of Contents
Active Drug Ingredients:
Oxytetracycline (from oxytetracycline dihydrate)
equivalent to oxytetracycline hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . . 100 g/lb
Neomycin Sulfate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 g/lb
Caution:
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
CAUTION: For use in manufacturing medicated animal feeds only.
CAUTION: Certain components of animal feeds, including medicated premixes, possess properties that may be a potential health hazard or a source of personal discomfort to certain individuals who are exposed to them. Human exposure should, therefore, be minimized by observing the general industry standards for occupational health and safety.
Precautions such as the following should be considered: dust masks or respirators and protective clothing should be worn; dust-arresting equipment and adequate ventilation should be utilized; personal hygiene should be observed; wash before eating or leaving a work site; be alert for signs of allergic reactions—seek prompt medical treatment if such reactions are suspected.
Store In A Dry, Cool Place
STORE AT OR BELOW 25°C (77°F), EXCURSIONS PERMITTED UP TO 40°C (104°F)
NEO-TERRAMYCIN is a registered trademark of Pfizer, Inc
licensed to Phibro Animal Health Corporation for Neomycin-Oxytetracycline
PHIBRO and PHIBRO logo design are trademarks owned by
Phibro Animal Health Corporation of its affiliates.
Phibro Animal Health Corporation, Teaneck, NJ 07666
Mixing And Use Directions
Mix Neo-Terramycin 100/100D with nonmedicated milk replacer to provide the following drug concentrations:
Indications for Use | Oxytetracycline and Neomycin Amount | lb. of Neo-Terramycin 100/100D per ton1 |
CALVES (milk replacer) | ||
For calves (up to 250 lb) for treatment of bacterial enteritis caused by E. coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin | 10 mg/lb of body weight daily Feed continuously for 7-14 days Treatment should continue 24 to 48 hours beyond remission of disease symptoms. | 202 |
CALVES, BEEF CATTLE, AND NONLACTATING DAIRY CATTLE | ||
Treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin | 10 mg/lb of body weight daily Feed continuously for 7-14 days Treatment should continue 24 to 48 hours beyond remission of disease symptoms. | 202 |
WARNING: A withdrawal period has not been established in preruminating calves; do not use in calves to be processed for veal. At the 10 mg/lb level, withdraw 5 days before slaughter. Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues. A milk discard time has not been established for use in lactating dairy cattle. Do not use in female dairy cattle 20 months of age or older. | ||
1Mixing directions are for example only and are based on mixing 1 lb of dry milk replacer with 1 gallon of water. 2If calf weighs 100 lb, consuming 1 gallon of milk replacer per day. | ||
Indications & Usage
FOR USE IN ANIMAL FEEDS ONLY
NOT FOR HUMAN USE
RESTRICTED DRUG (CALIFORNIA) – USE ONLY AS DIRECTED
* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.